Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-12-28

FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for fluoxetine from Dr. Reddy's Laboratories Limited, indicating a labeling-related update to the generic antidepressant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE)